InVivo Therapeutics (NASDAQ:NVIV) stock is rocketing higher on Tuesday despite a lack of news from the clinical-stage biomaterials and biotechnology company this morning. Instead, it looks like ...

InVivo Therapeutics is a research and clinical-stage biotechnology company focused on the development of technologies for the treatment of spinal cord injuries (SCIs). InVivo’s mission is to ...

Key Players Covered In This Report: Teva Pharmaceutical Industries Ltd., AbbVie Inc, Pfizer Inc., Reddy's Laboratories Ltd, Zydus Cadila, ReNetX Bio, Inc, InVivo Therapeutics Holdings, Lineage ...